Antonchuk Jennifer, Sauvageau Guy, Humphries R Keith
Terry Fox Laboratory, British Columbia Cancer Agency, 601 West 10th Avenue, V5Z 1L3, Vancouver, British Columbia, Canada.
Cell. 2002 Apr 5;109(1):39-45. doi: 10.1016/s0092-8674(02)00697-9.
Hox transcription factors have emerged as important regulators of primitive hematopoietic cell proliferation and differentiation. In particular, HOXB4 appears to be a strong positive regulator of hematopoietic stem cell (HSC) self-renewal. Here we demonstrate the potency of HOXB4 to enable high-level ex vivo HSC expansion. Cultures of nontransduced or GFP-transduced murine bone marrow cells experienced large HSC losses over 10-14 days. In sharp contrast, cultures of HOXB4-transduced cells achieved rapid, extensive, and highly polyclonal HSC expansions, resulting in over 1000-fold higher levels relative to controls and a 40-fold net HSC increase. Importantly, these HSCs retained full lympho-myeloid repopulating potential and enhanced in vivo regenerative potential, demonstrating the feasibility of achieving significant ex vivo expansion of HSCs without functional impairment.
Hox转录因子已成为原始造血细胞增殖和分化的重要调节因子。特别是,HOXB4似乎是造血干细胞(HSC)自我更新的强大正调节因子。在此,我们证明了HOXB4在体外实现高水平HSC扩增的能力。未转导或绿色荧光蛋白(GFP)转导的小鼠骨髓细胞培养物在10 - 14天内经历了大量HSC损失。与之形成鲜明对比的是,HOXB4转导细胞的培养物实现了快速、广泛且高度多克隆的HSC扩增,相对于对照组,其水平高出1000倍以上,HSC净增加40倍。重要的是,这些HSC保留了完整的淋巴细胞 - 髓细胞重建潜力和增强的体内再生潜力,证明了在无功能损害的情况下实现HSC显著体外扩增的可行性。